Atossa Therapeutics, Inc. Recorded Big Gain
Mon, Apr 06, 2020 at 05:30 PM
Atossa Therapeutics, Inc. (ATOS:NASDAQ) shot up at $1.5, a gain of 44.2%. The stock got featured on our News Catalysts scanner on Thu 02 Apr 20 at 11:26 AM in the 'BIOTECH' category. From Fri 20 Mar 20, the stock recorded 60.00% Up Days and 54.55% Green Days
About Atossa Therapeutics, Inc. (ATOS:NASDAQ)
Atossa Genetics Inc is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
Top 10 Gainers:
- Akers Biosciences, Inc. (AKER:NASDAQ), 146.84%
- Immunomedics, Inc. (IMMU:NASDAQ), 99.79%
- Exantas Capital Corp. (XAN:NYSE), 57.55%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 55.72%
- Associated Capital Group, Inc. (AC:NYSE), 48.82%
- Mesoblast Limited (MESO:NASDAQ), 46.67%
- Atossa Therapeutics, Inc. (ATOS:NASDAQ), 44.23%
- Braemar Hotels & Resorts, Inc. (BHR:NYSE), 43.55%
- Pensare Acquisition Corp. (WRLS:NASDAQ), 43.33%
- Cherry Hill Mortgage Investment Corporation (CHMI:NYSE), 41.52%